Navigation Links
FDA Approves Multaq(R) for Patients with Atrial Fibrillation or Atrial Flutter
Date:7/2/2009

of these conditions (71% of these patients had no heart failure, 29% were in NYHA class I-III with stable heart failure). This trial showed that Multaq(R) (dronedarone) 400 mg BID, in addition to standard therapy, reduced the combined endpoint of cardiovascular hospitalization or death from any cause by 24% (p<0.001) when compared to placebo, meeting the study's primary endpoint. This reduction was generally consistent across study subgroups based on baseline characteristics or medications. Patients taking Multaq(R) had higher rates of diarrhea, nausea, bradycardia, QT-interval prolongation and cutaneous rash than patients taking placebo.

Initiation of Multaq(R) treatment is contraindicated in patients with severe heart failure (NYHA class IV) or NYHA Class II - III heart failure with a recent decompensation requiring hospitalization or referral to a specialized heart failure clinic. This unstable population corresponds to the population of the ANDROMEDA trial in which patients receiving dronedarone had a greater than 2-fold increase in mortality compared to placebo.

The ATHENA and ANDROMEDA trials provided two sets of data supporting the assessment of the product's benefit risk ratio in two significantly different patient populations.

To ensure the use of Multaq(R) in the appropriate patient population, sanofi-aventis U.S. LLC also announced the launch of mPACT(TM) - Multaq(R) Partnership for Appropriate Care and Treatment - the Risk Evaluation and Mitigation Strategy (REMS) developed by sanofi-aventis U.S. LLC. The mPACT(TM) Partnership was developed to assist healthcare professionals (HCPs) with the identification of appropriate patients and to ensure the safe use of Multaq(R) while minimizing risk. The risk mitigation program consists of a Communication Plan for HCPs, a medication guide for patients and post-marketing surveillance.

"We are pleased that the FDA has granted approval of Mu
'/>"/>

SOURCE sanofi-aventis
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7

Related medicine news :

1. FDA Approves Lamictal(R)XR(TM); An Extended-Release Once-Daily, New Generation Treatment for Epilepsy
2. FDA Approves Reclast(R) to Prevent Osteoporosis in Postmenopausal Women With Convenient Less Frequent Dosing
3. FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia
4. ClearWay Minnesota(SM) Board Approves Four Regional Grants
5. Department of Defense Approves ISSA as Fitness Education Provider to Military Spouses
6. FDA Approves ACTOplus met(R) XR (pioglitazone HCl and metformin HCl extended-release) Tablets for the Treatment of Type 2 Diabetes
7. Treating Untreatable Brain Tumors: FDA Approves New Laser Surgery
8. FDA Approves Lamictal(R) ODT(TM) Orally Disintegrating Tablets
9. Video: FDA approves Exforge HCT(R) - the Only High Blood Pressure Treatment to Combine Three Medications in a Single Pill
10. Kaiser Permanente Approves $13 Million in Community Benefit Grants in First Quarter of 2009
11. FDA Approves Plan B Pill for 17-Year-Olds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... In a May 14, 2013 article entitled ... Discovering Cancer Gene,” Fox News reported the movie star ... she carried a gene that doctors estimated gave her ... 50 percent risk of ovarian cancer (go to: goo.gl/5JHBP). ... 2013 with a blog post entitled “A Patient’s Journey: ...
(Date:5/18/2013)... Springs, FL (PRWEB) May 18, 2013 The ... dedicated to the special places we call home. These are ... on maps. They are the locations where the people are ... first-rate show takes viewers off the highways and shares the ... best of both nations with an American sports and film ...
(Date:5/18/2013)... Family Magazine of Washington DC was awarded the ... Consulting, Inc. in the category of Summer Camps in ... of the areas best in the ultimate guide on parenting, ... than Brenda Hyde, a mother of four and publisher of ... the vast resources available to them in the DC Metro ...
(Date:5/18/2013)... 2013 The “Sleep Apnea Diagnostic & ... Masks, Adaptive Servo-Ventilation (ASV), Oral Appliances, Nasal EPAP, Neurostimulation] ... analyzes and studies the major market drivers, restraints, and ... the World. , Browse , ... Figures , 318 pagesand in-depth TOC ...
(Date:5/18/2013)... (PRWEB) May 18, 2013 The California ... 2013 therapies. At the Ayurvedic Spa , the ... panchakarma practitioner and lifestyle recommendations and stress ... “knowledge of life", is the traditional healthcare system of ... life of harmony is the basis for all optimum ...
Breaking Medicine News(10 mins):Health News:Angelina Jolie – Scarless Breast Augmentation Surgery 2Health News:Communities of Distinction TV Presents "A Place to Call Home" Segment 2Health News:Summer Camps in DC "Best of the Best" Awarded to Family Magazine of Washington DC for Excellence by Follow Media Consulting, Inc. 2Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 2Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 3Health News:Ayurveda Spa Treatments Now Offered at the California College of Ayurveda Panchakarma Center 2
... ... patients win the battle against the epidemic of untreated sleep apnea by offering special incentives ... ... a Southern California sleep apnea expert, has found a way to help patients win the ...
... ... Foundation (NSF) has announced that Larta Institute ( www.larta.org ), one ... has been tapped to design and manage a commercialization assistance program ... agencies, specifically the National Institutes of Health, the United States Department ...
... , MILFORD, Mass., Aug. 27 Waters ... first time in Europe the Waters((R)) SYNAPT(TM) G2 a system ... International Mass Spectrometry Conference (IMSC). Rounding out its display of ... IMSC will be Waters Xevo(TM) family of tandem quadrupole and ...
... , ... Fastrack HME, DME, IV Billing Software incorporates major technology advances to reduce operating ... ... Fastrack announced today the availability of significant technology enhancements designed to improve productivity ...
... ... audience recognizing why very few people enjoy yellow clothes or household objects. There is a ... ... 5th largest Unity Church in the United States, not a hand was raised when award-wining ...
... ... rollout of its state-of-the-art computerized quality and service management tool, OPTIMETRIX(TM), ... Indicators, PQRI, and HCAHPS measures. With OPTIMETRIX(TM) in place, a hospital,s ... to measure and improve both the quality of care and the ...
Cached Medicine News:Health News:Sleep Apnea Expert Offers Incentives That Could Save Lives 2Health News:Sleep Apnea Expert Offers Incentives That Could Save Lives 3Health News:Larta Institute Wins National Science Foundation (NSF) Contract 2Health News:Larta Institute Wins National Science Foundation (NSF) Contract 3Health News:SYNAPT G2's Power, Versatility and Speed Headlines Comprehensive Portfolio of Mass Spectrometers at IMSC 2Health News:SYNAPT G2's Power, Versatility and Speed Headlines Comprehensive Portfolio of Mass Spectrometers at IMSC 3Health News:SYNAPT G2's Power, Versatility and Speed Headlines Comprehensive Portfolio of Mass Spectrometers at IMSC 4Health News:SYNAPT G2's Power, Versatility and Speed Headlines Comprehensive Portfolio of Mass Spectrometers at IMSC 5Health News:New Fastrack Technology Improves Productivity 2Health News:New Fastrack Technology Improves Productivity 3Health News:ColorAlchemy Presentation at 5th Largest Unity Church Reveals How Yellow Commands Greater Personal Power 2Health News:ColorAlchemy Presentation at 5th Largest Unity Church Reveals How Yellow Commands Greater Personal Power 3Health News:ColorAlchemy Presentation at 5th Largest Unity Church Reveals How Yellow Commands Greater Personal Power 4Health News:Anesthetix Launches OPTIMETRIX(TM) Perioperative Quality Management Tool 2Health News:Anesthetix Launches OPTIMETRIX(TM) Perioperative Quality Management Tool 3
(Date:5/17/2013)... , May 17, 2013 Fuse Science, Inc. (OTCQB: ... company that is developing new, patent-pending technologies poised to redefine ... that it will hold a business update teleconference and webcast ... nd , 2013 at 4:30 PM ET. ... will host the call and will be joined by ...
(Date:5/17/2013)... May 17, 2013  Atossa Genetics, Inc. (NASDAQ: ... Kyle Guse , Chief Financial Officer & General ... Conference on Thursday, May 30, 2013, in New ... The Company,s presentation is scheduled to begin at ... webcast. To access the webcast, go to www.atossagenetics.com . ...
(Date:5/17/2013)... 2013 Sinovac Biotech Ltd. (Nasdaq: SVA ... , today announced that it will release its unaudited ... before market on Tuesday, May 28, 2013.  The Company will ... 8:00 a.m. EDT (May 28, 2013 at 8:00 p.m. China ... an update on recent corporate developments. To access ...
Breaking Medicine Technology:Fuse Science, Inc. to Hold Business Update Webcast and Teleconference on May 22nd 2Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 2Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 3Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 2Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: